Abstract
BackgroundMethotrexate (MTX) is the agent of first choice for the treatment of children with Juvenile Idiopathic Arthritis (JIA). Leflunomide (LFN) has demonstrated to be an effective alternative to MTX. There...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have